Updated Monday through Friday
- Drug Firm Annual Registration Status
- Drug Firm Annual Registration Status Download File
- National Drug Code Directory
- NDC Unfinished Drugs Excluded Database File
- NDC Database Excluded Packages and Products
- Wholesale Distributor and Third-Party Logistics Providers Reporting
January 30, 2020
- CDER Statement: FDA revises generic drug application prioritization policy to ensure fairness to applicants, efficiently allocate limited agency resources, and protect the public health
- FDA Drug Shortages
- Hydroxyzine Pamoate Oral Capsules (Updated - Currently in Shortage)
- Vincristine Sulfate Injection, USP (Preservative-Free) (Updated - Resolved)
- Manual of Policies and Procedures (MAPP) 5240.3 Rev.5 Prioritization of the Review of Original ANDAs, Amendments, and Supplements
- Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims Guidance for Industry
- Guidance Agenda: Guidances CDER is Planning to Develop During the Calendar Year 2020
.png)
No hay comentarios:
Publicar un comentario